Curis
CRIS
#10199
Rank
C$24.17 M
Marketcap
C$1.87
Share price
0.00%
Change (1 day)
-68.08%
Change (1 year)

Curis (CRIS) - Total assets

Total assets on the balance sheet as of September 2025 : C$38.28 Million

According to Curis's latest financial reports the company's total assets are C$38.28 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Curis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$59.21 M-42.23%
2023-12-31C$0.10 B-30.6%
2022-12-31C$0.14 B-28.59%
2021-12-31C$0.20 B-20.62%
2020-12-31C$0.26 B468.29%
2019-12-31C$45.85 M-9.92%
2018-12-31C$50.89 M-45.14%
2017-12-31C$92.78 M19.55%
2016-12-31C$77.61 M-41.09%
2015-12-31C$0.13 B81.3%
2014-12-31C$72.66 M-15.3%
2013-12-31C$85.78 M23.65%
2012-12-31C$69.37 M41.56%
2011-12-31C$49 M-3.2%
2010-12-31C$50.62 M33.29%
2009-12-31C$37.98 M-21.87%
2008-12-31C$48.61 M-9.45%
2007-12-31C$53.68 M-11.78%
2006-12-31C$60.85 M-14.19%
2005-12-31C$70.91 M-12.31%
2004-12-31C$80.87 M11.85%
2003-12-31C$72.3 M-26.69%
2002-12-31C$98.62 M-57.23%
2001-12-31C$0.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Exelixis
EXEL
C$3.91 B 10,115.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$2.02 B 5,185.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$0.14 B 289.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.89 B 2,245.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$289.08 B 755,049.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$134.18 B 350,426.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$28.16 M-26.43%๐Ÿ‡บ๐Ÿ‡ธ USA